Adlai Nortye

Adlai Nortye is a global clinical-stage biopharmaceutical company, headquartered in Hangzhou, China with US operations in New Jersey, developing differentiated immuno-oncology and precision-targeted cancer medicines. Its pipeline covers two therapeutic areas: precision RAS pathway targeted therapies — the oral pan-RAS(ON) inhibitor AN9025 and the CEACAM5-targeting antibody-drug conjugate AN4035 built on the company's proprietary RASiCA (RAS Inhibitor Conjugated Antibody) platform — and next-generation PD-1/L1 pathway modulating immunotherapies including AN8025, a multi-functional T-cell and antigen-presenting-cell modulating fusion protein, plus the oral EP4 antagonist AN0025 (palupiprant). The company is listed on Nasdaq under the ticker ANL. Adlai Nortye publishes no developer program, API, SDK or machine-readable contract of any kind.

Adlai Nortye is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Healthcare.

Adlai Nortye’s developer surface includes support and 13 more developer resources.

🌐 Visit website 📡 Source on GitHub

10.7/100 minimal Agent 0/100 human only Full breakdown ↓
scored 2026-09-07 · rubric v0.20.0

0 APIs

Company Biotechnology Pharmaceuticals Life Sciences Healthcare Oncology Clinical Trials Drug Development

Kin Score

Kin Score How this is scored →
scored 2026-09-07 · rubric v0.20.0

Composite quality — 10.7/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.8 / 17

Access Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Well-Known Document 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/adlai-nortye: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Adlai Nortye Domain Security

TLSv1.2 · HSTS

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 2

Status, limits, changes, and where to get help

PressReleases

PressReleases

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 6

The organization behind the API

Website

About

Careers

Partners

LinkedIn

Twitter

Twitter

Other 2

Properties that don't map to a standard resource type

x-DrugPipeline

x-DrugPipeline

x-SecondaryMarket

x-SecondaryMarket

Source (apis.yml)

aid: adlai-nortye
name: Adlai Nortye
description: 'Adlai Nortye is a global clinical-stage biopharmaceutical company, headquartered in Hangzhou, China with US
  operations in New Jersey, developing differentiated immuno-oncology and precision-targeted cancer medicines. Its pipeline
  covers two therapeutic areas: precision RAS pathway targeted therapies — the oral pan-RAS(ON) inhibitor AN9025 and the CEACAM5-targeting
  antibody-drug conjugate AN4035 built on the company''s proprietary RASiCA (RAS Inhibitor Conjugated Antibody) platform —
  and next-generation PD-1/L1 pathway modulating immunotherapies including AN8025, a multi-functional T-cell and antigen-presenting-cell
  modulating fusion protein, plus the oral EP4 antagonist AN0025 (palupiprant). The company is listed on Nasdaq under the
  ticker ANL. Adlai Nortye publishes no developer program, API, SDK or machine-readable contract of any kind.'
image: https://www.adlainortye.com/static/web/img/logob_20210415.svg
url: https://raw.githubusercontent.com/api-evangelist/adlai-nortye/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-07'
modified: '2026-09-07'
position: Producing
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Healthcare
- Oncology
- Clinical Trials
- Drug Development
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/adlai-nortye-domain-security.yml
- type: Website
  url: https://www.adlainortye.com/
- type: About
  url: https://www.adlainortye.com/index.php/about
- type: x-DrugPipeline
  url: https://www.adlainortye.com/index.php/products
- type: PressReleases
  url: https://www.adlainortye.com/index.php/news
- type: Support
  url: https://www.adlainortye.com/index.php/contact
- type: TermsOfService
  url: https://www.adlainortye.com/index.php/termOfUse
- type: PrivacyPolicy
  url: https://www.adlainortye.com/index.php/privacyPolicy
- type: Careers
  url: https://www.adlainortye.com/index.php/recruit
- type: Partners
  url: https://www.adlainortye.com/index.php/partner_business
- type: LinkedIn
  url: https://www.linkedin.com/company/adlainortye/
- type: Twitter
  url: https://x.com/AdlaiNortyeBio
- type: x-SecondaryMarket
  url: https://forgeglobal.com/adlai-nortye_stock/
- type: LLMsTxt
  url: llms/adlai-nortye-llms.txt
x-enrichment:
  date: '2026-09-07'
  status: minimal
  artifacts_added: 3
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: 'Adlai Nortye is a clinical-stage oncology drug developer (Nasdaq: ANL) whose product is a molecule, not software
    - its corporate site has no developer, docs or API section at all, and every contract probe across www, ir and cn returned
    403 or 404.'
  evidence:
  - url: https://www.adlainortye.com/openapi.json
    status: 404
  - url: https://www.adlainortye.com/llms.txt
    status: 404
  - url: https://www.adlainortye.com/.well-known/agent-card.json
    status: 403
  - url: https://www.adlainortye.com/apis.json
    status: 404
  - url: https://ir.adlainortye.com/
    status: 403
  checked: '2026-09-07'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools →

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/adlai-nortye"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/adlai-nortye/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/adlai-nortye/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.